Cargando…
Immune Parameters for Diagnosis and Treatment Monitoring in Invasive Mold Infection
Infections caused by invasive molds, including Aspergillus spp., can be difficult to diagnose and remain associated with high morbidity and mortality. Thus, early diagnosis and targeted systemic antifungal treatment remains the most important predictive factor for a successful outcome in immunocompr...
Autores principales: | Jenks, Jeffrey D., Rawlings, Stephen A, Garcia-Vidal, Carol, Koehler, Philipp, Mercier, Toine, Prattes, Juergen, Lass-Flörl, Cornelia, Martin-Gomez, M Teresa, Buchheidt, Dieter, Pagano, Livio, Gangneux, Jean-Pierre, van de Veerdonk, Frank L., Netea, Mihai G., Carvalho, Agostinho, Hoenigl, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958498/ https://www.ncbi.nlm.nih.gov/pubmed/31888227 http://dx.doi.org/10.3390/jof5040116 |
Ejemplares similares
-
The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update
por: Jenks, Jeffrey D., et al.
Publicado: (2020) -
Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
por: Jenks, Jeffrey D, et al.
Publicado: (2018) -
2567. Diagnosis of Invasive Aspergillosis in Hematological Malignancy Patients Receiving Mold-Active Antifungals: Performance of Interleukin-6 and -8, Asp LFD, and Aspergillus PCR in Same-day Blood and Bronchoalveolar Lavage Fluid Samples
por: Hoenigl, Martin, et al.
Publicado: (2018) -
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
por: Arastehfar, Amir, et al.
Publicado: (2020) -
Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement
por: Jenks, Jeffrey D., et al.
Publicado: (2020)